# Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet

> **NCT04122716** · PHASE4 · UNKNOWN · sponsor: **Signe Torekov** · enrollment: 215 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Liraglutide
- **BEHAVIORAL:** Exercise

## Key facts

- **NCT ID:** NCT04122716
- **Lead sponsor:** Signe Torekov
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2019-11
- **Final completion:** 2021-11
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2020-11-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04122716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04122716, "Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04122716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*